Zhongxin Wang

Chinese PLA General Hospital

Papers

3

Total Citations

86

H-Index

2

About

Dr. Zhongxin Wang is a pioneering urologic surgeon whose research focuses on advanced robotic-assisted techniques for managing complex urologic cancers, particularly renal cell carcinoma (RCC) and muscle-invasive bladder cancer. His most impactful work addresses the challenging differentiation and treatment of inferior vena cava (IVC) thrombus in RCC patients. In a landmark multi-institutional analysis (54 citations), Dr. Wang developed a decision-making scheme for robot-assisted cavectomy versus thrombectomy for Level II IVC thrombus, providing crucial surgical guidance. He further advanced diagnostic precision by demonstrating the high accuracy of contrast-enhanced ultrasound (CEUS) in distinguishing bland thrombus from tumor thrombus (30 citations), a critical distinction that prevents unnecessary aggressive surgery. Dr. Wang has also contributed to reconstructive urology, reporting on robot-assisted radical cystectomy with an intracorporeal Mainz II rectosigmoid pouch. His work directly impacts clinical decision-making, offering less invasive options for patients with complex disease while maintaining oncologic rigor. Through these contributions, Dr. Wang is shaping the future of robotic urologic oncology.

Research Focus

Key Achievements

2
H-Index
3
Papers
86
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Cavectomy Versus Thrombectomy for Level II Inferior Vena Cava Thrombus: Decision-making Scheme and Multi-institutional Analysis
54 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Chinese PLA General Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago